Haney Caelán M, Studier-Fischer Alexander, Probst Pascal, Fan Carolyn, Müller Philip C, Golriz Mohammad, Diener Markus K, Hackert Thilo, Müller-Stich Beat P, Mehrabi Arianeb, Nickel Felix
Department of General, Visceral, and Transplantation Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
Department of General, Visceral, and Transplantation Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany; Study Center of the German Surgical Society, Im Neuenheimer Feld 130, 69120 Heidelberg, Germany.
HPB (Oxford). 2021 Oct;23(10):1467-1481. doi: 10.1016/j.hpb.2021.03.006. Epub 2021 Mar 18.
BACKGROUND/PURPOSE: The dissemination of laparoscopic liver resection (LLR) has been based on non-randomized studies and reviews of these. Aim of this study was to evaluate if the randomized evidence comparing LLR to open liver resection (OLR) supports these findings.
A prospectively registered (reviewregistry866) systematic review and meta-analysis following Cochrane and PRISMA guidelines comparing LLR to OLR for benign and malignant diseases was performed via Medline, Web of Science, CENTRAL up to 31.12.2020. The main outcome was postoperative complications. Risk of bias was assessed with the Cochrane Risk of Bias tool 2.0, certainty of evidence was assessed using the GRADE approach.
The search yielded 2080 results. 13 RCTs assessing mostly minor liver resections with 1457 patients were included. There were reduced odds of experiencing any complication (Odds ratio (OR) [95% confidence interval (CI)]: 0·42 [0·30, 0·58]) and severe complications (OR[CI]: 0·51 [0·31, 0·84]) for patients undergoing LLR. LOS was shorter (Mean difference (MD) [CI]: -2·90 [-3·88, -1·92] days), blood loss was lower (MD: [CI]: -115·41 [-146·08, -84·75] ml), and functional recovery was better for LLR. All other outcomes showed no significant differences.
LLR shows significant postoperative benefits. RCTs assessing long-term outcomes and major resections are needed.
背景/目的:腹腔镜肝切除术(LLR)的推广是基于非随机研究及其综述。本研究的目的是评估比较LLR与开腹肝切除术(OLR)的随机证据是否支持这些发现。
按照Cochrane和PRISMA指南,通过检索Medline、Web of Science、CENTRAL直至2020年12月31日,对LLR与OLR治疗良性和恶性疾病进行前瞻性注册(reviewregistry866)的系统评价和荟萃分析。主要结局为术后并发症。使用Cochrane偏倚风险工具2.0评估偏倚风险,采用GRADE方法评估证据的确定性。
检索得到2080条结果。纳入13项随机对照试验,共1457例患者,主要评估小范围肝切除术。接受LLR的患者发生任何并发症(比值比(OR)[95%置信区间(CI)]:0·42 [0·30, 0·58])和严重并发症(OR[CI]:0·51 [0·31, 0·84])的几率降低。LLR患者的住院时间更短(平均差(MD)[CI]:-2·90 [-3·88, -1·92]天),失血量更低(MD:[CI]:-115·41 [-146·08, -84·75] ml),功能恢复更好。所有其他结局均无显著差异。
LLR显示出显著的术后益处。需要进行评估长期结局和大范围切除术的随机对照试验。